Redifferentiation-facilitated radioiodine therapy in thyroid cancer.

Abstract excerpt

Based on experimental data, the inhibition of the MAPkinase pathway in patients with radioiodine-refractory thyroid cancer was capable of inducing a redifferentiation. Preliminary data obtained in a small series of patients were encouraging and this strategy might become an alternative treatment in those patients with a druggable mutation that induces a stimulation of the MAP kinase pathway. This is an active...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to bioluminescence and chemiluminescence research
• Share to Iodine Radioisotopes